Deletions of multidrug resistance gene loci in breast cancer leads to the down-regulation of its expression and predict tumor response to neoadjuvant chemotherapy

Neoadjuvant chemotherapy (NAC) is intensively used for the treatment of primary breast cancer. In our previous studies, we reported that clinical tumor response to NAC is associated with the change of multidrug resistance (MDR) gene expression in tumors after chemotherapy. In this study we performed...

Descripción completa

Detalles Bibliográficos
Autores principales: Litviakov, Nikolai V., Cherdyntseva, Nadezhda V., Tsyganov, Matvey M., Slonimskaya, Elena M., Ibragimova, Marina K., Kazantseva, Polina V., Kzhyshkowska, Julia, Choinzonov, Eugeniy L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884957/
https://www.ncbi.nlm.nih.gov/pubmed/26799285
http://dx.doi.org/10.18632/oncotarget.6953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884957/
https://www.ncbi.nlm.nih.gov/pubmed/26799285
http://dx.doi.org/10.18632/oncotarget.6953

Ejemplares similares